Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals.

CRISPR/Cas9 is a gene editing tool that has revolutionized biomedical research and led to the first FDA-approved CRISPR-based gene therapy. However, until now, the precise mechanism of exactly how ...

Jennifer Doudna, one of the inventors of the breakthrough gene-editing tool CRISPR, says the technology will help the world ...

Spanish biotech Integra Therapeutics has upped its arsenal of gene editing tools by licensing Caszyme’s Cas12I nucleases, the ...

CRISPR/Cas9 is a gene editing tool that has revolutionized biomedical research and led to the first FDA-approved CRISPR-based gene therapy.

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a biotechnology company that develops a platform for cell programming, addressing challenges across various industries. The company has bolstered its ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...

The ABCA4 gene is large, so standard gene replacement therapy is ... Second, CRISPR-Cas9 and other DNA editing tools require ...

The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.

David H. Holman, Lestin L. Kenton Jr. and Kristina Caggiano Kelly of Sterne, Kessler, Goldstein & Fox PLLC discuss ...

often by adding a functioning copy of a gene. Genome editing began making its way into clinical trials in the mid-2000s. In ...